Advertisement

Topics

Haber, Inc. Company Profile

02:51 EDT 23rd June 2017 | BioPortfolio

Haber, Inc. is a high technology process development company with proprietary technologies in extractive metallurgy and electrochemical separations. The company’s Electromolecular Propulsion (EMP) technology is an electrochemical process that enables the electrically controlled movement or positioning of a variety of different molecules at greater speed and control of the results than conventional methods. In addition, the company has the environmentally friendly Haber Gold Process Four (HGP4), a sulfide reduction, extraction and recovery process and the associated “Aladdin” proprietary processing equipment. For more information, call Florence Tambone 617-710-1598 or visit the company’s website at http://www.habercorp.com


News Articles [8 Associated News Articles listed on BioPortfolio]

Emerging Company Partner David B. Haber Joins WilmerHale in New York

NEW YORK, Jan. 31, 2017 (GLOBE NEWSWIRE) -- David B. Haber has joined WilmerHale as a partner in New York, where his experience serving emerging companies will strengthen the firm's commitment to the...

New insights into DNA repair

A new paper in the prestigious journal Nature from Brandeis researchers in the laboratory of James Haber provides a detailed description of the processes of DNA repair.

Weyl semimetals split water

Catalysis significantly affects our way of life. Catalysis plays an important role in many biological and technological processes. For example, the world's food supply is based on a famous catalytic ...

Therapix Biosciences Announces CEO Change

TEL AVIV, Israel, May 24, 2017 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix"), a specialty clinical stage pharmaceutical Company specializing in the development of cannabin...

Turkey says could suspend EU migrant deal if no progress on visas

Turkey could re-evaluate or suspend all agreements under its migration deal with the European Union if the bloc does not give a positive response on visa-free travel for Turks, Foreign Minister Mevlut...

Jordan Edwards: Texas police officer fired for shooting and killing black teenager

The police officer who shot and killed a 15-year-old African American teenager in a car as he was leaving a party has been fired. Officer Roy Oliver shot high school freshman Jordan Edwards with a ri...

DoctorLogic Partners With DentalWorks to Successfully Launch 164 Unique Websites in Under 6 Months

DALLAS, Jan. 31, 2017 /PRNewswire/ -- Dallas-based software developer, DoctorLogic, recently launched 164 unique websites for DentalWorks and DentalOne Partners, Inc., one of the nation's largest dent...

Therapix Biosciences Announces the Appointment of Josh Blacher as Chief Financial Officer

TEL AVIV, Israel, May 3, 2017 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix"), a specialty clinical stage pharmaceutical company specializing in the development of cannabinoid-ba...

Drugs and Medications [0 Results]

None

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

Microbes and the next Nitrogen revolution.

The Haber Bosch process is among the greatest inventions of the 20th century. It provided agriculture with reactive nitrogen and ultimately mankind with nourishment for a population of 7 billion peopl...

Effects of Tempol and Quercetin on Human Sperm Function after Cryopreservation.

  BACKGROUND: Quercetin is a flavonoid with high reactive oxygen species (ROS) scavenging and ion chelating activity. It also enhances the activity of antioxidant enzymes and reduces enzymatic act...

Innominate segment deformation during passive hip abduction and external rotation.

Electromagnetic palpation-digitization technique for measurement of innominate motion involves calculation of innominate rotation using the innominate vector length in the neutral (NEUT) and combined ...

N2 activation on Al metal clusters: catalyzing role of BN-doped graphene support.

The successful sustenance of life demands an ambient abiotic process for N2 activation and dissociation. The Bosch-Haber process remains the only abiotic and synthetic means for N2 activation and its ...

Critical elements for human health risk assessment of less than lifetime exposures.

Less than lifetime exposure has confronted risk assessors as to how to interpret the risks for human health in case a chronic health-based limit is exceeded. Intermittent, fluctuating and peak exposur...

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

haber corporation

Since the inception in 1977 the vision of Gary Haber & Haber Corporation was to be and currently is a company dedicated to strengthening artists' and entertainers' careers by providing state-of-the-ar...

Haber, Inc.

Haber, Inc. is a high technology process development company with proprietary technologies in extractive metallurgy and electrochemical separations. The company’s Electromole...

Haber Incorporated

Haber Inc. has been an innovative high tech Company based in New Jersey, U.S.A. Today the company controls several proprietary cutting edge technologies, which are now commercial ready, and has begun ...

Shapiro Haber & Urmy LLP

More Information about "Haber, Inc." on BioPortfolio

We have published hundreds of Haber, Inc. news stories on BioPortfolio along with dozens of Haber, Inc. Clinical Trials and PubMed Articles about Haber, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Haber, Inc. Companies in our database. You can also find out about relevant Haber, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record